An Observational Follow-up Study to Evaluate Duration of Treatment Effect of Pentosan Polysulfate Sodium in Participants With Knee Osteoarthritis Pain
Active, not recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Drug: Pentosan Polysulphate SodiumDrug: Placebo (Sodium Chloride Injection, 0.9%)
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Paradigm Biopharmaceuticals USA (INC)
- Target Recruit Count
- 133
- Registration Number
- NCT04814719
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇦🇺Emeritus Research, Camberwell, Victoria, Australia
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
Phase 2
Active, not recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Drug: Placebo (Sodium Chloride Injection, 0.9%)Drug: Pentosan Polysulfate Sodium twice weeklyDrug: Pentosan Polysulfate Sodium once weeklyDrug: Pentosan Polysulfate Sodium Fixed Dose
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Paradigm Biopharmaceuticals USA (INC)
- Target Recruit Count
- 602
- Registration Number
- NCT04809376
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Discovery Clinical Trials, San Antonio, Texas, United States
🇺🇸Biosolutions Clinical Research Center, La Mesa, California, United States
© Copyright 2025. All Rights Reserved by MedPath